Golden
Mitsubishi UFJ Capital

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT and high technology investments.

Mitsubishi UFJ Capital is the venture capital arm of the Mitsubishi UFJ Financial Group, founded in 1974. Mitsubishi UFJ Capital uses the networks and resources of the MUFG Group to assist venture startups in growing their business. Based in Tokyo, Japan, the firm invests in sectors such as infrastructure technology, electronics, biotechnology and healthcare.



Investment

Mitsubishi UFJ Capital's investments include UniFa, AuB, ActEvolve, Kyash, HoloEyes, Asilla, proteanTecs and Modulated Imaging.



They exited their investments in Kyriba, Uzabase, Gengo, RareJob, Humanigen, NeoPhotonics, iPierian, ObjectVideo and Cara Therapeutics.



Funds

Mitsubishi UFJ Capital has raised a total of ¥20B across 2 funds, their latest being Mitsubishi UFJ Life Science I. This fund was announced on Feb 20, 2017 and raised a total of ¥10B.

Timeline

Funded Companies

11 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Symphony Communication Services provides a cloud-based communications platform.

A company focused on the discovery and development of therapies for neurodegenerative diseases

ticketstreet is a company founded by Kei Nishiyama.

Humanigen is a Brisbane, California-based company.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References